Personal information

No personal information available

Activities

Collapse all

Employment (2)

Karolinska Institutet: Stockholm, SE

2024-02-01 to present | Postdoctoral researcher (Women and children’s health )
Employment
Source: Self-asserted source
Okan Gultekin

Karolinska Institutet: Stockholm, Stockholm, SE

2020-01-01 to 2024-01-26 | Ph.D. candidate (Microbiology, Cell and Tumor Biology, MTC)
Employment
Source: Self-asserted source
Okan Gultekin

Professional activities (1)

European Association For Cancer Research: Nottingham, Nottingham, GB

2020-01-01 to present
Service
Source: Self-asserted source
Okan Gultekin

Works (27)

The mechanical anisotropy of adipose tissues regulates ovarian cancer invasion

2024-11-26 | Preprint
DOI: 10.1101/2024.11.25.625153
Contributors: Jordi Gonzalez-Molina; Parisa Nabili; Daniele Marciano; Sara Abdelnabi; Okan Gultekin; Mohammed Fatih Rasul; Yikun Zhang; Clémence Nadal; Alexandra Chrysanthou; Twana Alkasalias et al.
Source: check_circle
Crossref

MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness

Molecular Oncology
2024-04 | Journal article
DOI: 10.1002/1878-0261.13440
Contributors: Jordi Gonzalez‐Molina; Paula Hahn; Raul Maia Falcão; Okan Gultekin; Georgia Kokaraki; Valentina Zanfagnin; Tirzah Braz Petta; Kaisa Lehti; Joseph W. Carlson
Source: check_circle
Crossref

CXCR2-mediated recruitment of adaptive NK cells with NKG2C/HLA-E dependent antigen-specific memory enhances tumor killing in ovarian cancer

2024-03-31 | Preprint
DOI: 10.1101/2024.03.28.585607
Contributors: Yizhe Sun; Andrea Rodgers-Furones; Okan Gultekin; Shruti Khare; Shi Yong Neo; Wenyang Shi; Lidia Moyano Galceran; Kong-Peng Lam; Ramanuj Dasgupta; Jonas Fuxe et al.
Source: Self-asserted source
Okan Gultekin

The extracellular matrix – immune microenvironment crosstalk in cancer therapy: Challenges and opportunities

Matrix Biology
2023-08 | Journal article
DOI: 10.1016/j.matbio.2023.07.003
Contributors: Lara Closset; Okan Gultekin; Sahar Salehi; Dhifaf Sarhan; Kaisa Lehti; Jordi Gonzalez-Molina
Source: check_circle
Crossref

Data from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513447
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Data from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.c.6513447.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S1 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429767.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S1 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429767
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S2 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429761.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S2 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429761
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S3 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429758.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S3 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429758
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S4 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429755.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S4 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429755
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S5 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429752.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S5 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429752
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S6 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429749.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Figure S6 from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429749
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Supplementary Data from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429746.v1
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Supplementary Data from Mesothelin-Specific CAR T Cells Target Ovarian Cancer

2023-03-31 | Preprint
DOI: 10.1158/0008-5472.22429746
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

YAP and collagen remodelling support cell proliferation and tumour aggressiveness in uterine leiomyosarcoma

2022-06-29 | Preprint
DOI: 10.1101/2022.06.27.497746
Contributors: Jordi Gonzalez-Molina; Paula Hahn; Raul Maia Falcão; Okan Gultekin; Georgia Kokaraki; Valentina Zanfagnin; Tirzah Braz Petta; Kaisa Lehti; Joseph W. Carlson
Source: check_circle
Crossref

Chemotherapy as a regulator of extracellular matrix-cell communication: implications in therapy resistance

Seminars in Cancer Biology
2022-03 | Journal article
DOI: 10.1016/j.semcancer.2022.03.012
Part of ISSN: 1044-579X
Source: Self-asserted source
Okan Gultekin

FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation

npj Precision Oncology
2021-12 | Journal article
DOI: 10.1038/s41698-021-00236-6
Part of ISSN: 2397-768X
Source: Self-asserted source
Okan Gultekin

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance

Nature Communications
2021-06-23 | Journal article
DOI: 10.1038/s41467-021-24009-8
Contributors: Elina A. Pietilä; Jordi Gonzalez-Molina; Lidia Moyano-Galceran; Sanaz Jamalzadeh; Kaiyang Zhang; Laura Lehtinen; S. Pauliina Turunen; Tomás A. Martins; Okan Gultekin; Tarja Lamminen et al.
Source: check_circle
Crossref

Mesothelin-Specific CAR T Cells Target Ovarian Cancer

Cancer Research
2021-06-01 | Journal article
DOI: 10.1158/0008-5472.CAN-20-2701
Contributors: Esther Schoutrop; Ibrahim El-Serafi; Thomas Poiret; Ying Zhao; Okan Gultekin; Rui He; Lidia Moyano-Galceran; Joseph W. Carlson; Kaisa Lehti; Moustapha Hassan et al.
Source: check_circle
Crossref

Regulatory FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation

2021-03-28 | Preprint
DOI: 10.1101/2021.03.26.437169
Contributors: Okan Gultekin; Jordi Gonzalez-Molina; Elin Hardell; Lidia Moyano-Galceran; Nicholas Mitsios; Jan Mulder; Georgia Kokaraki; Anders Isaksson; Dhifaf Sarhan; Kaisa Lehti et al.
Source: check_circle
Crossref

CD11c-CD8 Spatial Cross Presentation: A Novel Approach to Link Immune Surveillance and Patient Survival in Soft Tissue Sarcoma

Cancers
2021-03-09 | Journal article
DOI: 10.3390/cancers13051175
Contributors: Yanhong Su; Panagiotis Tsagkozis; Andri Papakonstantinou; Nicholas P. Tobin; Okan Gultekin; Anna Malmerfelt; Katrine Ingelshed; Shi Yong Neo; Johanna Lundquist; Wiem Chaabane et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎
How many people are using ORCID?